officially retracts the paper entitled, “Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells” by Weilu Li, Yongjun Jiang, Xia Wu, and Fucun Yang (Cancer Biother Radiopharm 2019;34(7):480–485; doi: 10.1089/cbr.2018.2664) due to the discovery that the paper was submitted from a paper mill which is a violation of the journal's standard protocols.
The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves and does not tolerate any violations of scientific misconduct.
ChenW, ZhengR, BaadePD, et al.Cancer statistics in China, 2015. CA Cancer J Clin, 2016; 66:115.
3.
McCabeN, KennedyRD, PriseKM. The role of PTEN as a cancer biomarker. Oncoscience, 2016; 3:54.
4.
OuY, HoWS. Crocodile blood extract induces the apoptosis of lung cancer cells through PTEN activity. Oncol Rep, 2016; 36:1457.
5.
XinR, BaiF, FengY, et al.MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer. Clin Res Hepatol Gastroenterol, 2016; 40:748.
6.
WuYR, QiHJ, DengDF, et al.MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol, 2016; 37:12061.
7.
NodouziV, NowrooziM, HashemiM, et al.Concurrent down-regulation of PTEN and NKX3.1 expression in Iranian patients with prostate cancer. Int Braz J Urol, 2015; 41:898.
8.
AhearnTU, PetterssonA, EbotEM, et al.A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer. J Natl Cancer Inst, 2015; 108:djv346.
9.
TaoZQ, ShiAM, LiR, et al.Role of microRNA in prostate cancer stem/progenitor cells regulation. Eur Rev Med Pharmacol Sci, 2016; 20:3040.
TorreLA, BrayF, SiegelRL, et al.Global cancer statistics, 2012. CA Cancer J Clin, 2015; 65:87.
14.
LoebS, LiljaH, VickersA. Beyond prostate-specific antigen: Utilizing novel strategies to screen men for prostate cancer. Curr Opin Urol, 2016; 26:459.
15.
NakaoT, GeddisAE, FoxNE, et al.PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1). Cell Cycle, 2008; 7:257.
16.
PengH, DuB, JiangH, et al.Over-expression of CHAF1A promotes cell proliferation and apoptosis resistance in glioblastoma cells via AKT/FOXO3a/Bim pathway. Biochem Biophys Res Commun, 2016; 469:1111.
17.
DeyP, StromA, GustafssonJA. Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. Oncogene, 2014; 33:4213.
18.
CornforthAN, DavisJS, KhanifarE, et al.FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene, 2008; 27:4422.
19.
HanDF, ZhangJX, WeiWJ, et al.Fenofibrate induces G0/G1 phase arrest by modulating the PPARalpha/FoxO1/p27 kip pathway in human glioblastoma cells. Tumour Biol, 2015; 36:3823.
20.
LiuMH, LinXL, LiJ, et al.Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells. Mol Med Rep, 2016; 13:1689.
21.
LiuMH, LiGH, PengLJ, et al.PI3K/Akt/FoxO3a signaling mediates cardioprotection of FGF-2 against hydrogen peroxide-induced apoptosis in H9c2 cells. Mol Cell Biochem, 2016; 414:57.
22.
BassiC, MakTW. Regulation of the phosphatidylinositide 3-kinase pathway by the lipid phosphatase PTEN. Clin Chem, 2016; 62:884.
23.
ZhuG, BakerSJ. Detecting PTEN and PI3K signaling in brain. Methods Mol Biol, 2016; 1388:53.
24.
NohBJ, SungJY, KimYW, et al.Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer. Oncol Lett, 2016; 11:3621.
25.
GaoT, MeiY, SunH, et al.The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis. Biomed Pharmacother, 2016; 83:114.
26.
TianL, FangYX, XueJL, et al.Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro. PLoS One, 2013; 8:e75885.
27.
MahnR, HeukampLC, RogenhoferS, et al. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 2011;77:1265.e9.
